Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous NK Cells + Trastuzumab in HER2+ Breast and Gastric Cancer
NCT02030561Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Jan 2014
- Primary completion
- Aug 2017
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of autologous natural killer cells in HER2-positive breast cancer, Gastric cancer (HER2-positive), sponsored by National University Hospital. Status: unknown.
02
Drugs
autologous natural killer cells
03
Conditions
HER2-positive breast cancerGastric cancer (HER2-positive)
Beyond the preview
Go deeper on NCT02030561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02030561.